MajesTEC-4
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4
Near Add Your Location
- Accepting patients
Abramson Cancer Center - University of Pennsylvania (UPENN)
University of Pennsylvania
Philadelphia, PA
- Accepting patients
Medical University of South Carolina
Charleston, SC
- Accepting patients
- Not yet accepting
University of Cincinnati College of Medicine
George L. Strike Bone Marrow Transplant Program
Cincinnati, OH
- Accepting patients
- Accepting patients
- Not yet accepting
- Accepting patients
University of Arizona Cancer Center
Tucson, AZ
- Not yet accepting
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.